Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

S.A. Morrow, P.W. O'Connor, C.H. Polman, A.D. Goodman, L. Kappos, F.D. Lublin, R.A. Rudick, S. Jurgensen, D. Paes, F. Forrestal, R.H.B. Benedict

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1385-1392
JournalMultiple Sclerosis
Volume16
Issue number11
DOIs
Publication statusPublished - 2010

Cite this

Morrow, S.A. ; O'Connor, P.W. ; Polman, C.H. ; Goodman, A.D. ; Kappos, L. ; Lublin, F.D. ; Rudick, R.A. ; Jurgensen, S. ; Paes, D. ; Forrestal, F. ; Benedict, R.H.B. / Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. In: Multiple Sclerosis. 2010 ; Vol. 16, No. 11. pp. 1385-1392.
@article{b349c16db830402d8e16d848cd012152,
title = "Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks",
author = "S.A. Morrow and P.W. O'Connor and C.H. Polman and A.D. Goodman and L. Kappos and F.D. Lublin and R.A. Rudick and S. Jurgensen and D. Paes and F. Forrestal and R.H.B. Benedict",
year = "2010",
doi = "10.1177/1352458510378021",
language = "Undefined/Unknown",
volume = "16",
pages = "1385--1392",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "11",

}

Morrow, SA, O'Connor, PW, Polman, CH, Goodman, AD, Kappos, L, Lublin, FD, Rudick, RA, Jurgensen, S, Paes, D, Forrestal, F & Benedict, RHB 2010, 'Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks' Multiple Sclerosis, vol. 16, no. 11, pp. 1385-1392. https://doi.org/10.1177/1352458510378021

Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks. / Morrow, S.A.; O'Connor, P.W.; Polman, C.H.; Goodman, A.D.; Kappos, L.; Lublin, F.D.; Rudick, R.A.; Jurgensen, S.; Paes, D.; Forrestal, F.; Benedict, R.H.B.

In: Multiple Sclerosis, Vol. 16, No. 11, 2010, p. 1385-1392.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks

AU - Morrow, S.A.

AU - O'Connor, P.W.

AU - Polman, C.H.

AU - Goodman, A.D.

AU - Kappos, L.

AU - Lublin, F.D.

AU - Rudick, R.A.

AU - Jurgensen, S.

AU - Paes, D.

AU - Forrestal, F.

AU - Benedict, R.H.B.

PY - 2010

Y1 - 2010

U2 - 10.1177/1352458510378021

DO - 10.1177/1352458510378021

M3 - Article

VL - 16

SP - 1385

EP - 1392

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 11

ER -